MarkNtel Advisors recently published a detailed industry analysis of the Global Next Generation Immunotherapy Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Next Generation Immunotherapy Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029

The Next Generation Immunotherapy Market is projected to grow at a CAGR of around 7.5% during the forecast period, i.e., 2024-29.

Key Findings in Global Next Generation Immunotherapy Market:

Historical Analysis: 2019–2022

Base Year: 2023

Forecast Period: 2024–2029

Leading Market Players- Bristol Myers Squibb, Regeneron Pharmaceuticals, MacroGenics, AbbVie Inc., Pfizer Inc., Novartis, Merck & Co., Inc., AstraZeneca, Incyte Corporation, Eli Lilly and Company, Johnson and Johnson, Others

Key Highlights of the Report

Market Dimensions & Projections

Pricing Evaluation,

Recent Strategic Moves by Companies,

Primary Stakeholders,

Analysis of Import and Export Trends,

Competitive Landscape Assessment,

Emerging Opportunities,

Market Trends and Indicators

What are the major Driver the Global Next Generation Immunotherapy Market?

Growing Adoption of Chimeric Antigen Receptor (CAR) T-cell Therapy – In recent years, there has been a high demand for chimeric antigen receptor (CAR) T-cell therapy, which has been majorly driven by the rising prevalence of relapsed B-cell acute lymphoblastic leukemia (ALL) and specific non-Hodgkin lymphomas. For instance,

In 2020, according to the GLOBOCON, non-Hodgkin lymphomas (NHL) have been ranked as one of the most common cancers and had an estimated 544,000 new cancer cases and 260,000 cancer deaths in 2020.

The rising demand for CAR-T cell therapy among NHL patients has been majorly attributed to the superior clinical outcomes of chimeric antigen receptor (CAR) T-cell therapy arising from its proven success in treating challenging conditions. In addition, to cater to this rising demand for CAR-T cell therapy, companies have heightened funding into CAR-T cell therapy research & development, which led to the launch of new drugs. For instance,

In 2020, Tecartus, by Kite Pharma Inc., a CAR-T cell therapy was approved by the US FDA, which provided a significant treatment option for relapsed or refractory mantle cell lymphoma, expanding the application of CAR-T cell therapies of non-Hodgkin lymphoma.

Hence, with the availability of better next-generation immunotherapies, the market has experienced considerable growth. Moreover, the regulatory approvals and accelerated pathways granted by regulatory agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have played a crucial role in driving the adoption of CAR-T cell therapy. Hence, the established regulatory framework and clear pathways for approval would further facilitate the development and commercialization of CAR-T cell therapies, which would help in the market growth in the coming years as well.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

https://www.marknteladvisors.com/query/request-sample/next-generation-immunotherapy-market.html

What segments define the Global Next Generation Immunotherapy Market from 2024 to 2029? How do these segments contribute to market dynamics and growth?

By Type

Vaccines- Market Size & Forecast 2019-2029F, USD Million

mRNA Vaccines- Market Size & Forecast 2019-2029F, USD Million

DNA Vaccines- Market Size & Forecast 2019-2029F, USD Million

Protein Vaccines- Market Size & Forecast 2019-2029, USD Million

Others (Viral Vector Vaccines, Nanoparticle Vaccines, etc.)- Market Size & Forecast 2019-2029, USD Million

Immune Checkpoint Modulators- Market Size & Forecast 2019-2029F, USD Million

CAR-T Cell Therapy- Market Size & Forecast 2019-2029F, USD Million

Tumor-Infiltrating Lymphocytes (TILs) Therapy- Market Size & Forecast 2019-2029F, USD Million

Bispecific Antibodies- Market Size & Forecast 2019-2029F, USD Million

Oncolytic Virus Therapy- Market Size & Forecast 2019-2029F, USD Million

Others (Antibody-drug Conjugates, ACE Inhibitors, etc.)- Market Size & Forecast 2019-2029F, USD Million

By Route of Administration

Intravenous- Market Size & Forecast 2019-2029F, USD Million

Intratumoral- Market Size & Forecast 2019-2029F, USD Million

Subcutaneous- Market Size & Forecast 2019-2029F, USD Million

Oral- Market Size & Forecast 2019-2029F, USD Million

According to report, Among them, in recent years, the approach for intratumoral administration has surged in popularity due to its ability to elicit a stronger immune response, backed by promising clinical findings.

By Therapeutic Area

Oncology- Market Size & Forecast 2019-2029F, USD Million

Autoimmune Diseases- Market Size & Forecast 2019-2029F, USD Million

Infectious Diseases- Market Size & Forecast 2019-2029F, USD Million

Inflammatory Diseases- Market Size & Forecast 2019-2029F, USD Million

Others (Neurological Disorders, B-cell Malignancies, etc.) - Market Size & Forecast 2019-2029F, USD Million

According to report, Out of these, the oncology (cancer) segment has dominated the Global Next Generation Immunotherapy Market in recent years, owing to the rising prevalence of cancer across the globe.

By End User

Hospitals- Market Size & Forecast 2019-2029F, USD Million

Specialty Clinics- Market Size & Forecast 2019-2029F, USD Million

Ambulatory Surgical Centres- Market Size & Forecast 2019-2029F, USD Million

Cancer Research Centres- Market Size & Forecast 2019-2029F, USD Million

Explore the Complete Global Next Generation Immunotherapy Market Analysis Report – https://www.marknteladvisors.com/research-library/next-generation-immunotherapy-market.html

Geographical Analysis: Global Next Generation Immunotherapy Market

By Region

North America

South America

Europe

The Middle East & Africa

Asia-Pacific

Global Next Generation Immunotherapy Market Recent Development:

2023: Boehringer Ingelheim and 3T Biosciences have formed a strategic collaboration to leverage 3T Biosciences’ 3T-TRACE discovery platform and Boehringer Ingelheim’s research expertise to develop next-generation cancer therapies. Boehringer Ingelheim will supply patient-derived TCR data to support 3T’s antigen discovery using the TRACE platform, with 3T receiving initial payment and research backing.

2022: Regeneron Pharmaceuticals and CytomX Therapeutics have formed a collaboration to develop conditionally-activated bispecific cancer therapies by combining CytomX’s Probody platform and Regeneron’s Veloci-Bi bispecific antibody development platform, with a focus on improving the therapeutic window and reducing off-target effects in immunotherapies.

Key Questions Addressed in This Study

What are the primary factors driving the growth of the Global Next Generation Immunotherapy Market?

How is the Global Next Generation Immunotherapy Market expected to evolve over the next five years?

What key insights can be drawn from current trends shaping the market?

What is the current market size, and how is it forecasted to change in the coming years?

What is the future outlook for the market in terms of technological innovation and geographic expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/next-generation-immunotherapy-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2025 and is projected to reach USD 89 billion by 2029 with a CAGR of around 17.5%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2025 & is projected to reach USD 1.87 billion by 2029 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: sales@marknteladvisors.com

Trending Blogs : www.marknteladvisors.com/blogs

Export-import Data : https://www.marknteladvisors.com/export-import-data